Form D · Biotechnology
Cidara Therapeutics, Inc.
San Diego, CA · CIK 0001610618
Offering snapshot reported May 6, 2024 · SEC filing
- Reported sold
- $240M Offering amount: $240M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 24, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 6, 2024 | Initial | $240,000,000 | No comparison | 7 | SEC filing |
| Sep 13, 2019 | Initial | $9,008,173 | No comparison | 1 | SEC filing |
| May 30, 2018 | Initial | $1,562,499 | No comparison | 16 | SEC filing |
| Oct 31, 2017 | Initial | $20,160,000 | No comparison | 16 | SEC filing |
| Feb 17, 2015 | Initial | $42,019,999 | No comparison | 19 | SEC filing |
| Jun 17, 2014 | Initial | $6,000,472 | No comparison | 1 | SEC filing |
| Jun 17, 2014 | Initial | $30,332,199 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-512417
Source: Form D, filed May 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Abdollahian | Executive |
| Ken Bartizal | Executive |
| Bonnie Bassler, Ph.D. | Director |
| Dan Burgess | Director |
| Daniel D. Burgess | Director |
| Carin Canale Theakston | Director |
| Paul Daruwala | Executive |
| Steve Elms | Director |
| Kevin Forrest | Executive |
| Timothy R Franson | Director |
| David Gollaher | Director |
| Patrick Heron | Director |
| Kevin Judice | Director |
| Nina Kjellson | Director |
| James Levine | Executive |
| James Merson, Ph.D. | Director |
| Chrysa Mineo | Director |
| Jessica Oien | Executive |
| Matthew Onaitis | Executive |
| Robert J Perez | Director |
| Scott M Rocklage | Director |
| Taylor Sandison | Executive |
| Taylor Sandison, M.D. | Executive |
| Theodore R. Schroeder | Director |
| Ted Schroeder | Director |
| Preetam Shah, Ph.D. | Executive |
| Ryan Spencer | Director |
| Jeffrey Stein | Director, Executive |
| Jeffrey Stein, Ph.D. | Director, Executive |
| Laura Tadvalkar, Ph.D. | Director |
| Leslie Tari, Ph.D. | Executive |
| Dirk Thye | Executive |
| Shane Ward | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6310 Nancy Ridge Drive Suite 101
San Diego, CA, 92121
San Diego, CA, 92121